Dear Contractor
Correspondence has been issued by SPPG 15th April 2024 to those pharmacies yet to submit an evaluation survey for the Living Well campaign ‘Know Your Units’.

SUMMARY

  • The survey for the campaign ‘Know you Units’ opened on the 1stApril 2024 and can be accessed here
  • The survey must be completed by 6pm on 29th April 2024, please ensure to reach the final screen to confirm submission.

ACTION

  • Contractors who have yet to complete the Living Well survey for the campaign ‘Know Your Units’ are asked to read the correspondence issued by SPPG 15th April 2024 and share with relevant team members.
  • The survey for the campaign ‘Know Your Units’ is now available and must be completed before 6pm on 29th April 2024.

For any further information please contact CPNI offices.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive

Dear Colleague

The Department of Health and Social Care (DHSC) has published the initial list of concessionary prices for April 2024.  This announcement comes late in the month and follows the decision by DHSC, under the direction of Ministers, to impose changes to concessionary prices from April to try to manage purchase margins.  Community Pharmacy England has opposed these changes.  CPNI will continue to raise our concerns around the application of the English Drug Tariff in Northern Ireland with the Department of Health (NI).  The initial update of concessionary prices for April 2024 are as follows:

DrugPack SizeConcessionary Price
Amoxicillin 250mg/5ml oral suspension100£2.16
Anastrozole 1mg tablets28£1.38
Aripiprazole 10mg tablets28£6.88
Aripiprazole 15mg tablets28£7.30
Aripiprazole 5mg tablets28£6.12
Azithromycin 250mg capsules6£4.45
Baclofen 10mg tablets84£2.71
Bimatoprost 100micrograms/ml eye drops3£4.33
Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye drops3£8.75
Bumetanide 1mg tablets28£2.46
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel60£22.91
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment30£10.11
Cefalexin 250mg capsules28£2.04
Cefalexin 500mg capsules21£2.46
Chloramphenicol 0.5% eye drops10£4.35
Cinacalcet 30mg tablets28£7.79
Clarithromycin 125mg/5ml oral suspension70£4.03
Clarithromycin 250mg/5ml oral suspension70£5.50
Co-amoxiclav 250mg/125mg tablets21£2.44
Co-amoxiclav 500mg/125mg tablets21£3.84
Co-careldopa 25mg/100mg tablets100£7.55
Co-codamol 15mg/500mg tablets100£3.11
Co-codamol 30mg/500mg capsules100£5.70
Colecalciferol 1,000unit capsules30£5.89
Digoxin 125microgram tablets28£2.63
Digoxin 250microgram tablets28£2.51
Digoxin 62.5microgram tablets28£2.78
Docusate 50mg/5ml oral solution sugar free300£17.75
Donepezil 5mg tablets28£1.60
Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops 0.2ml unit dose preservative free60£24.03
Dorzolamide 20mg/ml eye drops5£3.55
Duloxetine 20mg gastro-resistant capsules28£7.52
Duloxetine 30mg gastro-resistant capsules28£1.98
Duloxetine 40mg gastro-resistant capsules56£11.25
Duloxetine 60mg gastro-resistant capsules28£3.06
Escitalopram 10mg tablets28£1.22
Escitalopram 20mg tablets28£1.43
Escitalopram 5mg tablets28£2.50
Esomeprazole 40mg gastro-resistant capsules28£2.81
Estradiol 10microgram pessaries24£9.40
Estriol 1mg/g vaginal cream15£5.36
Etoricoxib 30mg tablets28£4.03
Etoricoxib 60mg tablets28£11.89
Etoricoxib 90mg tablets28£11.42
Ezetimibe 10mg tablets28£10.10
Famotidine 40mg tablets28£28.37
Fenofibrate micronised 160mg tablets28£3.28
Haloperidol 1.5mg tablets28£3.23
Haloperidol 5mg tablets28£4.35
Irbesartan 300mg tablets28£1.25
Isotretinoin 20mg capsules30£9.83
Ketoconazole 2% shampoo120£17.51
Lactulose 3.1-3.7g/5ml oral solution500£3.38
Latanoprost 50micrograms/ml / Timolol 5mg/ml eye drops2.5£6.01
Lofepramine 70mg tablets56£18.05
Mebeverine 200mg modified-release capsules60£6.42
Memantine 10mg tablets28£1.20
Memantine 10mg/ml oral solution sugar free50£42.50
Memantine 20mg tablets28£1.60
Metformin 1g modified-release tablets56£3.19
Metformin 500mg modified-release tablets56£1.74
Methylphenidate 10mg tablets30£2.98
Metoclopramide 10mg tablets28£1.09
Midazolam 10mg/2ml solution for injection ampoules10£5.33
Mometasone 0.1% ointment30£3.38
Mometasone 50micrograms/dose nasal spray140£9.20
Montelukast 10mg tablets28£1.81
Morphine sulfate 10mg/1ml solution for injection ampoules10£8.03
Mycophenolate mofetil 500mg tablets50£6.50
Nebivolol 2.5mg tablets28£10.96
Nebivolol 5mg tablets28£6.00
Nortriptyline 10mg tablets100£2.33
Olanzapine 10mg tablets28£1.04
Ondansetron 4mg tablets10£6.06
Oxycodone 10mg/1ml solution for injection ampoules5£6.05
Paracetamol 500mg effervescent tablets100£5.57
Pregabalin 150mg capsules56£2.07
Pregabalin 200mg capsules84£4.50
Pregabalin 300mg capsules56£3.08
Pregabalin 50mg capsules84£24.00
Primidone 250mg tablets100£88.02
Prochlorperazine 3mg buccal tablets50£8.43
Propantheline bromide 15mg tablets112£100.61
Pyridostigmine bromide 60mg tablets200£17.44
Quetiapine 100mg tablets60£2.15
Quetiapine 150mg tablets60£2.74
Quetiapine 200mg tablets60£3.19
Quinine sulfate 200mg tablets28£7.05
Quinine sulfate 300mg tablets28£3.10
Rasagiline 1mg tablets28£36.00
Risperidone 2mg tablets60£1.92
Risperidone 4mg tablets60£2.22
Rizatriptan 10mg tablets3£6.67
Ropinirole 2mg tablets28£26.95
Ropinirole 500microgram tablets28£15.00
Simvastatin 20mg tablets28£1.04
Sodium chloride 0.9% nebuliser liquid 2.5ml unit dose ampoules20£9.50
Sodium valproate 200mg/5ml oral solution sugar free300£11.85
Tacrolimus 0.1% ointment60£35.28
Tamsulosin 400microgram / Dutasteride 500microgram capsules30£11.50
Temazepam 10mg tablets28£24.19
Terbinafine 1% cream30£6.87
Terbinafine 1% cream15£3.44
Trospium chloride 20mg tablets60£12.24
Zolmitriptan 2.5mg tablets6£16.45
Zolmitriptan 2.5mg tablets12£32.90
Zonisamide 100mg capsules56£23.31
Zonisamide 50mg capsules56£23.57

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Shortage Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
This update contains important information for community pharmacy teams.

CPNI ALERTS

DOH(NI) ALERTS

BSO ALERTS

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.
Or report medicine shortages, pricing and staffing issues via CPNI’s Medicine Shortage Reporter and Situation Reporter.
Please bring this to the attention of your pharmacy team(s).

Kind regards

SENT ON BEHALF OF
Gerard Greene
Chief Executive

Dear Contractor,

SPPG has written to Contractors to provide a 2024/25 Community Pharmacy Funding Update.

The letter confirms that Ministerial approval has been given to extend various additional funding allocations provided in 2023/24 into 2024/25.  This means that the community pharmacy funding position of £142.9m @ 31st March 2024 is carried over into 2024/25.  In addition, Ministerial approval of an advance payment of £1m per quarter (associated with the anticipated Global Sum and non-Global Sum uplifts in 2024/25) has also been given.  This therefore increases the opening funding allocation for 2024/25 to £147m.

A summary outline of the community pharmacy funding in 2023/24 and the opening 2024/25 community pharmacy funding can be found here.

Contractors are asked to read the letter and note the funding arrangements applicable from April 2024.

CPNI, while recognising the importance of the additional investment provided in 2023/24 by the Permanent Secretary and the Health Minister Mr Robin Swann MLA, has been consistent in stating that the sector was still under-funded by approximately £15m in 2023/24. The advance payment of £1m per quarter (associated with the anticipated GS and non-GS uplifts) is also welcome but with NMW/NLW increases, increased business overhead costs and Northern Ireland Drug Tariff changes all impacting Contractors further from this month, CPNI is concerned that the funding deficit is widening as we go into 2024/25.

CPNI continues to make representations to the Health Minister, DoH and SPPG officials and elected representatives and we encourage Contractors to continue engaging with the Health Minister and local MLA’s as well as raising public awareness of the sector difficulties through the CPNI public awareness campaign.

I would also ask contractors to continue notifying CPNI offices if your BSO payment(s) on 30th April 2024 are insufficient to meet wholesaler, payroll and pharmacy overhead costs this month.

Please do not hesitate to contact CPNI offices if you require any additional information.

Yours sincerely,

SENT ON BEHALF OF
GERARD GREENE
Chief Executive

Dear Contractor,

You will be aware that Community Pharmacy is in an unprecedented financial crisis.

Over recent weeks and months, CPNI has been in intensive discussions with the Health Minister and elected representatives to outline the financial challenges being faced by our sector – and the implications for patients and pharmacy services.

We are aware of the extremely difficult financial challenges of managing payments to wholesale suppliers. We know that there are increasing occasions when medicines cannot be supplied because cash flow is so restricted that payment to wholesalers cannot be made. We understand the frustration and despondency this is causing in the sector, and we know how diligently pharmacy contractors are working to look after the needs of their local community patients and customers.

Political Lobbying Campaign

We have met with the Health Minister and with the Permanent Secretary of the Department of Health on a number of occasions, and we have very recently briefed the Health Committee, and continue to engage with elected representatives. Many pharmacy contractors have independently written to the Minister, Health Committee members and civil servants to share their personal stories and to make a direct appeal for change. This has been a very important element of the lobbying campaign.

Changes we are calling for:

  • Urgent stabilisation of community pharmacy funding in the short-term and a re-set of community pharmacy funding.
  • Putting in place a Northern Ireland specific Drug Tariff that reflects Northern Ireland’s unique circumstances and that will assure sustainable service provision and medicine supply to patients going forward.
  • Investment in the community pharmacy network to further extend the range of community pharmacy services, so that we can continue to play a transformative role in helping to keep patients closer to home, for longer, and reducing pressures on general practice, out-of-hours, and secondary care.

Public Awareness Campaign

We are now putting this campaign in front of community pharmacy patients to explain why the current financial pressures mean that medicine supplies and pharmacy services cannot be guaranteed.

We rely on patients’ support, and we are asking for their understanding while this crisis is resolved.  We want patients to know that their local community pharmacy is doing its best and that this problem is affecting the whole community pharmacy sector in Northern Ireland.

In sharing this with patients, we are also seeking their support for our campaign. Pharmacies will by now have received campaign resource packs with information and materials which we hope will help you to create awareness and provide ways that patients and customers can give their support.

Campaign resource packs contained:

  • Posters for your window and in-store.
  • Petition sheets for the counter. These simply require the patient or customer’s name, postcode and a signature – no further address or contact details are required. Please encourage patients and customers to sign the petition.
  • A bundle of small flyers outlining the campaign and urging individuals to contact their local elected representatives.  These feature a QR code which can be scanned with a smartphone camera, to link to a page where they will find the contact details for their local politician.  The flyer will also provide suggested text for their correspondence.

This campaign will also be supported by social media assets which will be shared with you directly.

There is widespread political support for the role of community pharmacy services and it is important that the public voice is also loud and clear.

I would encourage you to make your pharmacists and the wider pharmacy team aware of the campaign and the important impact patients and customers can make in supporting it.

If you have any questions, please contact Jude Austin – judea@communitypharmacyni.co.uk

Yours sincerely,

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
For the attention of Community Pharmacies providing the Spring 2024 COVID-19 Community Pharmacy Vaccination Service
Dear Colleague
SPPG have issued correspondence providing an update in relation to the Spring 2024 COVID-19 Community Pharmacy Vaccination Service.

SUMMARY

CPVS update 2 includes information on topics including:

  1. The publication of the Vaccination Protocol.
  2. A reminder to ensure that VMS Entries for Care Home Residents include the RQIA Code.
  3. A reminder that pharmacies who have paired with a care home and who have submitted a contract to the SPPG, can now proceed to plan the dates for the vaccination clinic(s) in association with the respective care home(s).

ACTION

Contractors providing the service should:

Please do not hesitate to contact the CPNI office should you require any further information.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive